Rare Tumors
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.2 | Q4 | 10.8% | 0.370 | Q3 | 50.6% |
| 2024 | 0.9 | Q4 | 12.0% | 0.271 | Q3 | 42.1% |
| 2023 | 0.9 | Q4 | 11.1% | 0.251 | Q3 | 43.1% |
| 2022 | 0.9 | 11.9% | 0.256 | Q4 | 45.6% | |
| 2021 | — | 25.2% | 0.309 | Q3 | 52.3% | |
| 2020 | — | — | 0.285 | Q3 | 48.6% | |
| 2019 | — | — | 0.247 | Q4 | 46.0% | |
| 2018 | — | — | 0.244 | Q3 | 42.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2036-3613
ISSN
2036-3605
country
ITcoverage
2010-2026